Schmertzler Michaelinsider trades
In SEC Form 4 filings, Schmertzler Michael is listed as Director of Ptc Therapeutics, Inc. (PTCT) and Director, 10% owner of Hamilton Lane INC (HLNE). In the last 90 days, Schmertzler Michael sold $6.62M of Ptc Therapeutics, Inc. (PTCT) on the open market and bought none. All 20 sales were reported under a 10b5-1 trading plan.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PTCTPtc Therapeutics, Inc. | Oct 14 | Oct 16 | S | 2,118 | $59.52 | Sale −$126,063 | 1,291,976 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 14 | Oct 16 | S | 382 | $60.14 | Sale −$22,973 | 1,291,594 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 7 | Oct 9 | S | 2,447 | $63.38 | Sale −$155,091 | 1,294,147 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Oct 7 | Oct 9 | S | 53 | $63.95 | Sale −$3,389 | 1,294,094 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 17 | Sep 18 | S | 9,624 | $67.83 | Sale −$652,796 | 1,296,970 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 17 | Sep 18 | S | 376 | $68.45 | Sale −$25,737 | 1,296,594 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 16 | Sep 18 | S | 2,994 | $66.58 | Sale −$199,341 | 1,313,600 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 16 | Sep 18 | S | 7,006 | $67.35 | Sale −$471,854 | 1,306,594 | Yes | Form 4 |
| HLNEHamilton Lane INC | Sep 16 | Sep 18 | A | 977 | $0.00 | $0 | 977 | No | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 10 | Sep 11 | S | 10,000 | $67.34 | Sale −$673,400 | 1,316,594 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 9 | Sep 11 | S | 9,428 | $67.79 | Sale −$639,124 | 1,327,166 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Sep 9 | Sep 11 | S | 572 | $68.67 | Sale −$39,279 | 1,326,594 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 27 | Aug 28 | S | 11,890 | $71.55 | Sale −$850,730 | 1,337,204 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 27 | Aug 28 | S | 610 | $72.22 | Sale −$44,054 | 1,336,594 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 26 | Aug 28 | S | 6,874 | $72.74 | Sale −$500,015 | 1,354,720 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 26 | Aug 28 | S | 5,626 | $73.18 | Sale −$411,711 | 1,349,094 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 20 | Aug 21 | S | 9,419 | $70.78 | Sale −$666,677 | 1,364,675 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 20 | Aug 21 | S | 2,390 | $71.88 | Sale −$171,793 | 1,362,285 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 20 | Aug 21 | S | 691 | $72.92 | Sale −$50,388 | 1,361,594 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 19 | Aug 21 | S | 5,335 | $72.86 | Sale −$388,708 | 1,381,259 | Yes | Form 4 |
| PTCTPtc Therapeutics, Inc. | Aug 19 | Aug 21 | S | 7,165 | $73.67 | Sale −$527,846 | 1,374,094 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.